No Carolina / NY / Florida
Ph: 561.316.3330

Simon Hegele Healthcare Solutions Accelerates Global Growth Through Partnership with Brazil’s MR In Site

Summation

  • Simon Hegele Healthcare Solutions, a highly specialized service partner for original equipment manufacturers (OEMs) of large-scale medical equipment, announces a new partnership through a majority shareholder investment, in MR In Site, one of Brazil’s largest manufacturers of RF shielding and installation services provider of medical imaging equipment.
  • We are glad to have found a partner in Simon Hegele Healthcare Solutions that aligns with our values and we are looking forward to a great partnership.
  • “Not only does this alliance increase Simon Hegele’s capacity in Brazil, it rapidly enhances the variety of services we can bring to our combined customer bases uptilting the Hegele skill set and experience from around the globe.

Simon Hegele Healthcare Solutions, a highly specialized service partner for original equipment manufacturers (OEMs) of large-scale medical equipment, announces a new partnership through a majority shareholder investment, in MR In Site, one of Brazil’s largest manufacturers of RF shielding and installation services provider of medical imaging equipment. The agreement includes affiliates Brazil Riggers and Columbia Riggers, which specialize in the rigging and assembly of linear accelerator systems. Corresponding (preliminary) contracts have been concluded, closing will take place in the first half of 2023.

Located in São Paulo, MR In Site has deep experience in the electromedical equipment industry and earned a reputation for delivering exceptional service since their founding in 2005.

This partnership builds on Simon Hegele’s existing operations in Latin America and supports the ongoing global expansion of the company.

“Our partnership with MR In Site is a great opportunity to expand our capabilities in the South American market,” says Jim Nestel, CEO of the Americas and Asia Pacific for Simon Hegele Healthcare Solutions. “Not only does this alliance increase Simon Hegele’s capacity in Brazil, it rapidly enhances the variety of services we can bring to our combined customer bases uptilting the Hegele skill set and experience from around the globe.”

Alex Silva, MR In Site CEO and founder, adds “It was critical to us that our future partner shares the same dedication to quality and reliability as we do. At the end of the day, we are providing services that impact our surrounding community. We are glad to have found a partner in Simon Hegele Healthcare Solutions that aligns with our values and we are looking forward to a great partnership.”

More News

Moleculin Announces Commencement of NIH-Funded Phase 2 Clinical Trial of STAT3 Inhibitor for the Treatment of Glioblastoma (NU 21C06)

Investigator-Initiated Phase 2 study is being conducted at Northwestern University in cooperation with Moleculin. Trial combines WP1066 and radiation, which demonstrated both significant therapeutic response and immune "memory" in glioblastoma animal models

AbbVie and Gilgamesh Pharmaceuticals | Announce Collaboration and Option-to-License Agreement to Develop Next-Generation Therapies for Psychiatric Disorders

Under terms of the agreement, AbbVie and Gilgamesh Pharmaceuticals have agreed to research and develop a portfolio of next-generation therapeutics for psychiatric disorders.

PharmaLogic Announces Opening of Radiopharmaceutical Production Facility in New York City

Acquired in 2022, the facility has undergone extensive renovations and boasts state-of-the-art equipment, signifying the companys significant investment in fostering the development of novel radiopharmaceuticals in the region.

spot_img

By using this website you agree to accept Medical Device News Magazine Privacy Policy